CTOs on the Move

Counsyl

www.counsyl.com

 
Counsyl is a DNA testing and genetic counseling service that offers genetic screening for men, women and their children. Our philosophy is simple - focus on diseases where advanced knowledge makes a difference in health outcomes, whether it`s changing a behavior, pursuing preventative measures, or simply preparing for what lies ahead. Counsyl has screened over 750,000 patients and served over 10,000 health professionals in its modern clinical laboratory. From the purely mechanical to profoundly human, Counsyl strives to make genetic screening truly accessible to everyone. The team consists of world class engineers, scientists and clinical experts as well as a ...
  • Number of Employees: 250-1000
  • Annual Revenue: $50-100 Million
  • www.counsyl.com
  • 180 Kimball Way
    South San Francisco, CA USA 94080
  • Phone: 888.268.6795

Executives

Name Title Contact Details

Funding

Counsyl raised $80M on 11/06/2017

Similar Companies

Open Door Health Center

Open Door Health Center is a Homestead, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Whip Mix Corp.

Whip Mix is the one resource that helps the Dental Profession achieve its goals of high quality, less invasive patient care, reduced chair time and increased operating efficiencies.

Pearl City Nursing Home

Pearl City Nursing Home is a Pearl City, HI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

HMC HealthWorks

Say goodbye to a blanket approach to healthcare. We personalize each plan sponsor`s needs toward improving the health and quality of life of participants. The result? Reduced healthcare spend and a healthier population. HMC`s 40 years of clinically-based protocols produces an impact that engages, empowers and delivers.

RaNA Therapeutics

RaNA Therapeutics is pioneering the discovery of a new class of RNA-targeted medicines that selectively activate protein expression within the body`s own cells. By targeting specific genes, RaNA`s novel drugs work epigenetically to precisely upregulate the expression of beneficial proteins in order to treat or prevent disease. The company`s leadership leverages preeminent founders and advisors in the field, and the strength of its fundamental patents, technology, and know-how that underlie the discovery and development of therapeutics that selectively activate RNA. RaNA is applying its proprietary technology to rapidly advance a pipeline of novel drugs for diverse therapeutic areas, with an initial emphasis in the fields of rare genetic disorders, inflammation, oncology, metabolic diseases and neurodegenerative diseases.